hexoprenaline has been researched along with Atrial Fibrillation in 1 studies
Hexoprenaline: Stimulant of adrenergic beta 2 receptors. It is used as a bronchodilator, antiasthmatic agent, and tocolytic agent.
Atrial Fibrillation: Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frederiksen, MC | 1 |
| Toig, RM | 1 |
| Depp, R | 1 |
1 other study available for hexoprenaline and Atrial Fibrillation
| Article | Year |
|---|---|
Atrial fibrillation during hexoprenaline therapy for premature labor.
Topics: Adult; Atrial Fibrillation; Female; Hexoprenaline; Humans; Infant, Newborn; Infusions, Parenteral; O | 1983 |